How Much Does Compounded Semaglutide Cost in 2026?

Understanding compounded semaglutide cost in 2026 is more complex than comparing program prices, because hidden fees, dose escalations, and pharmacy quality all affect what you actually spend.

*This article is for informational purposes only. It is not medical advice. Speak with a licensed healthcare provider before starting any new medication or treatment program.*

---

If you have been researching compounded semaglutide cost, you have probably already experienced sticker shock. Brand-name semaglutide, the active ingredient in Ozempic and Wegovy, can run $800 to $1,000 or more per month without insurance. That is a significant barrier for most people, especially when obesity already carries enormous financial costs of its own.

Compounded semaglutide has changed the math for a lot of people. But the pricing landscape can be confusing. Some providers advertise low headline numbers while burying extra fees in the fine print. Others bundle everything cleanly. So what should you actually expect to pay, and what should you watch out for?

This guide breaks it all down clearly.

---

Why Semaglutide Costs Vary So Much

The price you pay for semaglutide depends on several factors working together, or against each other.

Brand vs. compounded. FDA-approved brand-name products like Ozempic and Wegovy carry the full weight of clinical trials, patent protections, and pharmaceutical manufacturer pricing. [Compounded semaglutide](/resources/compounded-semaglutide-what-it-is) is a GLP-1 receptor agonist prepared by a licensed compounding pharmacy rather than manufactured under an FDA-approved process. Compounded medications are not FDA-approved and are not the same as brand-name products. This difference in production pathway is a major driver of the cost gap.

Pharmacy overhead. A traditional retail pharmacy passes along significant overhead: physical locations, staff, insurance billing infrastructure. Telehealth-connected compounding pharmacies that ship directly can operate leaner.

Telehealth vs. in-person clinic. Seeing an obesity medicine specialist in person typically adds consultation fees, follow-up visit costs, and sometimes required lab work billed separately. Telehealth platforms can consolidate much of this into a simpler monthly fee.

Provider business model. Some platforms charge a low medication price but bill separately for consultations. Others layer on subscription fees. And some (like Prescriva) bundle everything into one flat monthly rate.

Understanding these variables is the only way to make a true apples-to-apples comparison.

---

Brand-Name vs. Compounded Semaglutide: The Cost Difference

For a deeper look at the differences beyond cost, see [Compounded Semaglutide vs. Ozempic](/resources/compounded-semaglutide-vs-ozempic) and [Compounded Semaglutide vs. Wegovy](/resources/compounded-semaglutide-vs-wegovy).

Let's put the numbers side by side.

Brand-name semaglutide (Wegovy / Ozempic) without insurance:

• Wegovy: approximately $1,349/month list price
• Ozempic: approximately $800-$1,000/month list price
• With a manufacturer savings card: potentially $0/month for commercially insured patients who qualify, but eligibility is limited and savings cards exclude government-insured patients (Medicare, Medicaid)
• With insurance: highly variable. Many plans do not cover Wegovy for weight loss, and prior authorization is increasingly required

The economic burden here is real. Obesity-related medical costs already add up to an estimated $260.6 billion annually in the United States, according to a large pooled analysis published in the *Journal of Managed Care & Specialty Pharmacy* (PMID: 33470881). The last thing people need is a medication that could help sitting out of reach due to cost.

Compounded semaglutide:

• Range: approximately $169–$300/month depending on provider and plan length (as of June 2026)
• Typically includes: medication plus some level of provider access
• What is included varies significantly by platform

Research on GLP-1 access has consistently found that high out-of-pocket costs are one of the primary barriers to treatment, even among people with obesity who stand to benefit most. Compounded options exist specifically to address this gap.

It is worth noting: compounded medications are not FDA-approved. The active ingredient is the same as the brand-name product, but the compounding process itself has not gone through the FDA's approval pathway. For a full safety analysis, see [Is Compounded Semaglutide Safe?](/resources/is-compounded-semaglutide-safe).

---

Price Comparison: Prescriva vs. Competitors

The table below reflects pricing information available as of April 2026. Prices are subject to change. Verify directly with each provider before purchasing.

*Prices current as of publication date and subject to change. Verify directly with each provider before purchasing. Compounded medications are not FDA-approved.*

A few things to note:

• Hims/Hers has been aggressive with promotional pricing (oral semaglutide as low as $49/month for a first month), but injectable compounded semaglutide pricing typically requires a longer upfront commitment.
• Ro's model involves a separate monthly membership fee in addition to medication cost, which can push the effective monthly total significantly higher than the headline number.
• MEDVi's $179 first-month price may differ from ongoing refill pricing. Always confirm the long-term rate.

---

What's Included in Prescriva's Monthly Price

Prescriva's pricing is designed to be transparent and all-inclusive. Here is what that monthly price covers:

Provider consultation. A licensed healthcare provider reviews your online health assessment before any prescription is written. You do not pay a separate "consultation fee" layered on top of medication costs.

Compounded semaglutide medication. Your medication is prepared by a licensed compounding pharmacy and shipped directly to you.

Shipping. There is no surprise shipping charge at checkout.

Ongoing provider access. Questions during your treatment? Prescriva's care model includes provider access, not just a one-time sign-off.

Prescriva's price ($289/month month-to-month, or as low as $169/month on the 52-week plan) is all-inclusive, with no separate consultation or pharmacy add-ons on top of it.

---

Hidden Costs to Watch For

When you are comparing compounded semaglutide providers, these are the line items that can catch people off guard:

Separate consultation fees. Some platforms charge $50-$150 for the initial provider visit, billed apart from your medication cost. Always ask: is the consultation included?

Lab work requirements. Certain providers require baseline bloodwork before prescribing, which is clinically reasonable, but the cost may not be included in the advertised price. Labs can run $50-$200+ depending on what is ordered and where.

Titration costs. As your dose increases over time (a standard part of GLP-1 protocols), some providers charge more for higher doses. Confirm whether your pricing is fixed or dose-dependent.

Refill pricing vs. introductory pricing. A $99 first-month offer sounds attractive until month two arrives at $299. Always ask for the ongoing refill price, not just the promotional rate.

Shipping fees. Particularly relevant for providers where the medication price looks low but standard shipping is not included.

Cancellation or membership fees. Some platforms operate on a subscription model with fees attached to pausing or canceling.

The cleanest way to compare is to calculate what you would actually pay over 3-6 months, including all fees, not just the first month.

---

Does Insurance Cover Compounded Semaglutide?

The short answer: generally no, and here is why.

Insurance coverage for semaglutide, even brand-name Wegovy, is already limited and inconsistent. As of recent analyses, only a minority of Medicaid programs in the U.S. cover GLP-1 medications for weight loss, and prior authorization requirements have increased significantly.

Compounded medications face an additional hurdle: because they are not FDA-approved products, most insurance plans will not reimburse for them. They are outside the formulary systems that insurance billing runs on.

What this means practically:

• You will likely pay out of pocket for compounded semaglutide, regardless of your insurance plan
• HSA (Health Savings Account) and FSA (Flexible Spending Account) funds may be usable for compounded semaglutide if prescribed by a licensed provider. Confirm with your plan administrator, as rules vary
• Some employers are beginning to offer GLP-1 coverage through supplemental benefits programs. This is worth checking with your HR department for brand-name options

For many people, the math makes compounded semaglutide the more immediate and accessible option, even when paying fully out of pocket.

---

Is Cheaper Always Worse? What to Look for in a Provider

Lower cost does not automatically mean lower quality, but it can. The key is knowing what legitimate compounded semaglutide looks like versus what raises concerns. For a full evaluation checklist, see [How to Evaluate a Compounded GLP-1 Provider](/resources/how-to-evaluate-compounded-glp1-provider-503a-pharmacy).

Green flags:

• Requires a prescription from a licensed provider (no "buy without a prescription" claims)
• Uses a licensed compounding pharmacy. Ask which one, and verify their license
• Offers clear provider oversight and follow-up support
• Discloses what pharmacy fulfills prescriptions
• All-inclusive monthly pricing that bundles consultation, medication, and shipping
• Has a real medical review process, not just a checkbox

Red flags:

• Sells compounded semaglutide without requiring a prescription
• No clinician review mentioned anywhere in the process
• Refuses to disclose which pharmacy prepares the medication
• Unusually low prices with no explanation of what is included
• No mechanism for side effect reporting or follow-up care

The STEP 1 trial of branded, FDA-approved semaglutide (Wegovy), published in the *New England Journal of Medicine* (PMID: 33567185), showed meaningful, sustained weight loss when used properly under clinical supervision: an average of 14.9% body weight reduction at 68 weeks. Compounded semaglutide has not been separately studied in equivalent trials, and these results should not be assumed to apply to compounded formulations. The clinical supervision piece is not optional. A provider that skips this step is cutting corners that matter.

A lower price from a legitimately operated telehealth platform with proper oversight is not a red flag. A suspiciously low price from a provider that does not mention a pharmacy, a prescriber, or a medical review is.

---

How to Start with Prescriva

Starting with Prescriva is straightforward:

1. Complete your online health assessment. Answer questions about your health history, current medications, and weight loss goals. This typically takes about 10 minutes.
2. A licensed provider reviews your information. If compounded semaglutide is appropriate for you, they will issue a prescription. If it is not right for you, they will tell you why.
3. Your medication ships from a licensed compounding pharmacy. Directly to your door. Shipping is included.
4. Ongoing support is part of the plan. You are not on your own once your medication arrives.

---

Frequently Asked Questions

What is the average cost of compounded semaglutide in 2026? Compounded semaglutide typically costs between $169 and $300 per month (as of June 2026) depending on the provider, dose, and what is included. Prescriva's all-inclusive price is $169/mo on the 52-week plan ($289/mo month-to-month) covering consultation, medication, and shipping.

Is compounded semaglutide cheaper than Ozempic or Wegovy? Yes, significantly. Brand-name Wegovy has a list price around $1,349/month and Ozempic runs $800-$1,000/month without insurance coverage. Compounded semaglutide from telehealth providers ranges from roughly $169–$300/month (as of June 2026).

Why does compounded semaglutide cost less than brand-name? Brand-name medications carry the cost of clinical trials, FDA approval, patent protections, and pharmaceutical manufacturer pricing. Compounded semaglutide is prepared by a licensed compounding pharmacy under a different regulatory pathway, which removes those costs. Compounded medications are not FDA-approved and are not the same as brand-name products.

Does insurance cover compounded semaglutide? Generally no. Because compounded medications are not FDA-approved products, they fall outside standard insurance formularies. HSA/FSA funds may be applicable. Check with your plan administrator.

What should be included in the monthly price? At minimum: the medication itself. Ideally: consultation/provider review, shipping, and ongoing provider access. Always ask what is included before signing up. Watch for separate consultation fees, lab requirements, and dose-based pricing increases.

Can I use my HSA or FSA for compounded semaglutide? Possibly, if it is prescribed by a licensed provider. HSA/FSA eligibility for compounded medications varies by plan. Confirm with your plan administrator before assuming coverage.

---

Disclaimer

*This content is for informational purposes only and is not medical advice. Consult your healthcare provider before starting any weight loss medication.*

*Compounded medications are not FDA-approved.*

*Compounded semaglutide is not the same as, equivalent to, or interchangeable with FDA-approved semaglutide products (Ozempic, Wegovy, or Rybelsus).*

*Results may vary. Individual results depend on adherence to treatment and lifestyle modifications.*

*All medical services, including prescribing, are provided by independently licensed healthcare providers. Blue Oak Services LLC dba Prescriva is a management services organization and does not practice medicine or make clinical decisions.*

*Ozempic and Wegovy are registered trademarks of Novo Nordisk A/S. Prescriva is not affiliated with, endorsed by, or sponsored by these companies.*

*Pricing comparisons are based on publicly available information as of the publication date. Prices are subject to change. Verify directly with each provider before purchasing.*

---

Sources:

1. Wilding JPH, et al. "Once-Weekly Semaglutide in Adults with Overweight or Obesity." *New England Journal of Medicine.* 2021. PMID: [33567185](https://pubmed.ncbi.nlm.nih.gov/33567185/)
2. Biener A, et al. "Direct Medical Cost of Obesity in the United States and the Most Populous States." *Journal of Managed Care & Specialty Pharmacy.* 2021. PMID: [33470881](https://pubmed.ncbi.nlm.nih.gov/33470881/)